Tezepelumab in Patients With Severe Asthma: Response at 3 Months.
Miralles-López JC, Andújar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, Ramírez-Hernández M, Díaz-Chantar C, Pajarón-Fernández MJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR GROUP.
Miralles-López JC, et al. Among authors: perez fernandez v.
J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041. Online ahead of print.
J Investig Allergol Clin Immunol. 2024.
PMID: 39584417
Free article.
No abstract available.